ABC Transporter C1 Prevents Dimethyl Fumarate from Targeting Alzheimer’s Disease
Alzheimer’s disease (AD), the leading cause of dementia, is a growing health issue with very limited treatment options. To meet the need for novel therapeutics, existing drugs with additional preferred pharmacological profiles could be recruited. This strategy is known as ‘drug repurposing’. Here, w...
Main Authors: | Luisa Möhle, Katja Stefan, Pablo Bascuñana, Mirjam Brackhan, Thomas Brüning, Ivan Eiriz, Ahmed El Menuawy, Sylvie van Genderen, Irene Santos-García, Anna Maria Górska, María Villa, Jingyun Wu, Sven Marcel Stefan, Jens Pahnke |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-06-01
|
Series: | Biology |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-7737/12/7/932 |
Similar Items
-
The Challenge of Dimethyl Fumarate Repurposing in Eye Pathologies
by: Federico Manai, et al.
Published: (2022-12-01) -
Repurposing Dimethyl Fumarate for Cardiovascular Diseases: Pharmacological Effects, Molecular Mechanisms, and Therapeutic Promise
by: Shilu Deepa Thomas, et al.
Published: (2022-04-01) -
Gliosis attenuation in experimental autoimmune encephalomyelitis by a combination of dimethyl fumarate and pregabalin
by: Amanda Garcia Hoelz, et al.
Published: (2022-08-01) -
Dimethyl Fumarate Triggers the Antioxidant Defense System in Human Retinal Endothelial Cells through Nrf2 Activation
by: Federico Manai, et al.
Published: (2022-09-01) -
Dimethyl Fumarate, an Approved Multiple Sclerosis Treatment, Reduces Brain Oxidative Stress in SIV-Infected Rhesus Macaques: Potential Therapeutic Repurposing for HIV Neuroprotection
by: Yoelvis Garcia-Mesa, et al.
Published: (2021-03-01)